Tr1X
The Director, Clinical Operations oversees the execution of clinical trials from start-up to close-out, leading cross-functional teams, managing CROs and vendors, and ensuring compliance with regulatory requirements and internal SOPs.
Tr1X is a clinical-stage biotechnology company engineering a novel class of regulatory T cell-based therapies to cure autoimmune and inflammatory diseases. Leveraging cutting-edge genetic engineering and deep immunology expertise, Tr1X develops allogeneic, off-the-shelf Tr1/Treg cell therapies designed to restore immune tolerance and reset the immune system. The company has four active clinical programs spanning Crohn's disease, multiple sclerosis, graft-versus-host disease prevention following stem cell transplant, and autoimmune uveitis.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tr1X.
26% above the average for this role
Clinical Trials Manager, Early Phase Oncology (Office Based)
Gilead Sciences
Clinical Operations Leader
GondolaBio Service Co, Inc.
Clinical Trials Manager- Late Phase Oncology (Office-Based)
Gilead Sciences
Sr. Clinical Trial Manager
Structure Therapeutics
Associate Director of Clinical Operations
Vor Bio
Clinical Program Manager
lifelancer